CapsoVision (CV) Share-based Compensation (2024 - 2025)
CapsoVision (CV) reported Share-based Compensation of -$291000.0 for Q3 2025, down 939.29% on a YoY basis from $34672.3 in Q3 2024, and down 939.29% sequentially from -$28000.0 in Q3 2024.
CapsoVision (CV) Share-based Compensation (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of Share-based Compensation data on file, last reported at -$291000.0 in Q3 2025.
- For the quarter ending Q3 2025, Share-based Compensation fell 939.29% year-over-year to -$291000.0; the trailing twelve-month figure through Dec 2025 stood at -$319000.0 (changed N/A YoY), and the FY2025 full-year result was $31000.0, changed N/A from the prior year.
- Share-based Compensation fell to -$291000.0 in Q3 2025, from -$28000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of -$28000.0 in Q3 2024 to a low of -$291000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -291,000.00 |
| Sep 30, 2025 | -291,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |